{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262945501497728.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1910607"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1910607"}}],"dc:title":[{"@value":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262945501497728","@type":"Researcher","foaf:name":[{"@value":"Enli Liu"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497609","@type":"Researcher","foaf:name":[{"@value":"David Marin"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497611","@type":"Researcher","foaf:name":[{"@value":"Pinaki Banerjee"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497734","@type":"Researcher","foaf:name":[{"@value":"Homer A. Macapinlac"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497731","@type":"Researcher","foaf:name":[{"@value":"Philip Thompson"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497735","@type":"Researcher","foaf:name":[{"@value":"Rafet Basar"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497729","@type":"Researcher","foaf:name":[{"@value":"Lucila Nassif Kerbauy"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497733","@type":"Researcher","foaf:name":[{"@value":"Bethany Overman"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497613","@type":"Researcher","foaf:name":[{"@value":"Peter Thall"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497616","@type":"Researcher","foaf:name":[{"@value":"Mecit Kaplan"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497736","@type":"Researcher","foaf:name":[{"@value":"Vandana Nandivada"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497600","@type":"Researcher","foaf:name":[{"@value":"Indresh Kaur"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497603","@type":"Researcher","foaf:name":[{"@value":"Ana Nunez Cortes"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497610","@type":"Researcher","foaf:name":[{"@value":"Kai Cao"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497614","@type":"Researcher","foaf:name":[{"@value":"May Daher"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497732","@type":"Researcher","foaf:name":[{"@value":"Chitra Hosing"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497612","@type":"Researcher","foaf:name":[{"@value":"Evan N. Cohen"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497604","@type":"Researcher","foaf:name":[{"@value":"Partow Kebriaei"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497605","@type":"Researcher","foaf:name":[{"@value":"Rohtesh Mehta"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497602","@type":"Researcher","foaf:name":[{"@value":"Sattva Neelapu"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497608","@type":"Researcher","foaf:name":[{"@value":"Yago Nieto"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497601","@type":"Researcher","foaf:name":[{"@value":"Michael Wang"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497730","@type":"Researcher","foaf:name":[{"@value":"William Wierda"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497607","@type":"Researcher","foaf:name":[{"@value":"Michael Keating"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497617","@type":"Researcher","foaf:name":[{"@value":"Richard Champlin"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497615","@type":"Researcher","foaf:name":[{"@value":"Elizabeth J. Shpall"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262945501497606","@type":"Researcher","foaf:name":[{"@value":"Katayoun Rezvani"}],"jpcoar:affiliationName":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2020-02-06","prism:volume":"382","prism:number":"6","prism:startingPage":"545","prism:endingPage":"553"},"reviewed":"false","dc:rights":["http://www.nejmgroup.org/legal/terms-of-use.htm"],"url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1910607"}],"createdAt":"2020-02-05","modifiedAt":"2024-03-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050865795853875840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280630816512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617664016640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development and characterisation of NKp44‐based chimeric antigen receptors that confer T cells with NK cell‐like specificity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643795601152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905163111168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cell therapies against brain tumors: Clinical development and emerging prospects"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905636691712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118804081152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579814662369664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"gBOIN‐ET: The generalized Bayesian optimal interval design for optimal dose‐finding accounting for ordinal graded efficacy and toxicity in early clinical trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593680245248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705585698048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Natural Killer Cell-Based Immunotherapy against Glioblastoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869854355505280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CAR-NK cells derived from cord blood originate mainly from CD56−CD7+CD34−HLA-DR−Lin− NK progenitor cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1390290769955560448","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current global trends in the development of CAR-T therapy"},{"@language":"ja","@value":"CAR-T療法開発；その最新の世界情勢"}]},{"@id":"https://cir.nii.ac.jp/crid/1390573242570321408","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2) Chimeric Antigen Receptor T-cell Therapy"},{"@language":"ja","@value":"2）遺伝子改変T細胞（CAR-T）療法"}]},{"@id":"https://cir.nii.ac.jp/crid/1391975831220044032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1910607"},{"@type":"CROSSREF","@value":"10.1016/s2352-3026(22)00045-x_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.1007/s00262-024-03808-0_references_DOI_PEE4qnsv7vAiFTzZWehiUxPL99E"},{"@type":"CROSSREF","@value":"10.1002/cti2.1147_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.1182/blood.2020007748_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.2169/naika.110.414_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.1002/btm2.70018_references_DOI_PEE4qnsv7vAiFTzZWehiUxPL99E"},{"@type":"CROSSREF","@value":"10.1038/s43018-025-00934-1_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.7889/tct-21-012_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.3390/cancers13112712_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.1002/bimj.202100263_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.1007/s12185-020-02951-5_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.3390/ijms24032111_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.1016/j.omtm.2024.101374_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"},{"@type":"CROSSREF","@value":"10.3960/jslrt.20036_references_DOI_HWh5wIw6fECWuWwlykxCGjBuhoQ"}]}